anti-human CXCL13 (BLC) monoclonal antibody Anti-Human 50 µg,Reliatech,101-M351

This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with human recombinant CXCL13 (also called BCL). The IgG1 fraction of the tissue culture supernatant was purified by Protein G affinity chromatograp

Host

Mouse

Reactivity

Human

Application

WB, N

Platform ID

BAB246972185

Reliatech

Headquarters

Lindener Straße 15 38300 Wolfenbüttel Germany

Reliatech

Contact

Tel: +49 (0) 5331 - 8586987
Fax: +49 (0) 5331- 8586989

Email:

[email protected]

Product Specifications
Scientific Background
Synonyms

Specifications

Nameanti-human CXCL13 (BLC) monoclonal antibody Anti-Human 50 µg
Cat. No.101-M351
Accession NumberO43927
HostMouse
IsotypeIgG1
ReactivityHuman
ApplicationWB, N
Clone Number(#12A2)
Appearance/Formlyophilized
FormulationPBS
ReconstitutionCentrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
StorageLyophilized samples are stable for 2 years from date of receipt when stored at -70°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
Regulatory StatusFor research use only

Scientific Background

NAP-2 or CXCL7 is a CXC chemokine that can signal through the CXCR1 and CXCR2 receptors. It is produced in leukocytes by enzymatic processing of a precursor called platelet basic protein (PBP). NAP-2 chemoattracts and activates neutrophils. Recombinant human NAP-2 protein is a 7.6 kDa protein containing 70 amino acid residues including the four highly conserved cysteine residues present in CXC chemokines, and also including the “ELR” motif common to CXC chemokines that bind to CXCR1 and CXCR2.

Synonyms

CXCL13; BLC; BCA1; ANGIE; BCA-1; BLR1L; ANGIE2; SCYB13

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.